Table 1. Top Enriched Pathways Associated with Differential Alternative Splicing Events.
Pathway | -log(P-value) |
---|---|
M0-HMDM vs M1-HMDM | |
Apoptosis Signaling | 6.03 |
PI3K/AKT Signaling | 4.15 |
mTOR Signaling | 4.08 |
CDK5 Signaling | 4.02 |
ERK/MAPK Signaling | 3.94 |
NF-κB Signaling | 2.04 |
M0-HMDM vs M2-HMDM | |
TWEAK Signaling | 3.47 |
TNFR1 Signaling | 3.03 |
PEDF / PPARγ Signaling | 2.54 |
Interferon Signaling | 2.11 |
PKR in inflammation | 1.95 |
Glycogen Biosynthesis | 1.70 |
Pre- vs Post-LPS PBMCs | |
IGF-1 Signaling | 2.10 |
Lipoate Salvage and Modification | 1.74 |
Cell Cycle Checkpoint Regulation | 1.57 |
Hypoxia Signaling in the Cardiovascular System | 1.57 |
Insulin Receptor Signaling | 1.51 |
Nitric Oxide Signaling in the Cardiovascular System | 1.51 |
Pathways identified by Ingenuity Pathway Analysis for genes that are differentially spliced in each experimental condition. LPS = lipopolysaccharide, PBMC = peripheral blood mononuclear cells, HMDM =human monocyte derived macrophage.